TOP TIERMARKET NEWSWIRE
News & sentiment

ARCUS BIOSCIENCES IN (RCUS) — News & AI sentiment

ARCUS BIOSCIENCES IN (RCUS) news roundup. 4 stories in the past week, 12 over 30 days. Average 30-day sentiment is 56.2/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 4 sales totalling $3.2M — net selling of $3.2M. US House Periodic Transaction Reports (90-day window): 0 purchases (~$0) and 1 sale (~$33K). Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
4
avg sentiment 56/100
30d stories
12
avg sentiment 56.2/100
Insider net (90d)
$3.2M
0 buys · 4 sells
Congress (90d)
-1
0 buys · 1 sells

Latest stories on RCUS

2d ago
2d ago
6d ago
H.C. Wainwright reiterates Arcus Biosciences stock rating at buy
Investing.com Analyst Ratings61 · neutralanalyst
7d ago
Jul 22
Jul 22
Jul 22
Jul 21
H.C. Wainwright raises Arcus Biosciences stock price target to $45
Investing.com Analyst Ratings61 · neutralanalyst
Jul 20
Jul 13
Jul 9
Jul 1
Jun 25
Jun 24
Jun 12
Arcus Biosciences, Inc. (RCUS) files 8-K
SEC 8-K50 · neutralgeneral
Jun 12
Jun 10
Jun 9
Jun 9
Jun 3
May 26
Open RCUS in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →